Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.67 USD | +1.66% | +0.27% | +20.33% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 40.03M | Capitalization | 309M |
---|---|---|---|---|---|
Net income 2024 * | -268M | Net income 2025 * | -255M | EV / Sales 2024 * | - |
Net cash position 2024 * | 518M | Net cash position 2025 * | 404M | EV / Sales 2025 * | -2.36 x |
P/E ratio 2024 * |
-1.15
x | P/E ratio 2025 * |
-1.21
x | Employees | 74 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.44% |
Latest transcript on Atea Pharmaceuticals, Inc.
1 day | +1.66% | ||
1 week | +0.27% | ||
1 month | -4.68% | ||
3 months | -17.53% | ||
6 months | +17.63% | ||
Current year | +20.33% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 12-11-30 | |
Andrea Corcoran
DFI | Director of Finance/CFO | 61 | 13-11-30 |
Maria Horga
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 19-08-31 |
Barbara Duncan
BRD | Director/Board Member | 59 | 20-09-30 |
Chief Executive Officer | 68 | 12-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.67 | +1.66% | 141,116 |
24-05-30 | 3.61 | +2.27% | 167,322 |
24-05-29 | 3.53 | -2.22% | 330,501 |
24-05-28 | 3.61 | -1.37% | 249,849 |
24-05-24 | 3.66 | -0.81% | 148,489 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.33% | 309M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- AVIR Stock